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†Department of Physics and ‡Department of Pharmacy and Pharmacology, University of Bath, Bath, United KingdomABSTRACT Understanding the structural organization and distribution of proteins in biological cells is of fundamental impor-
tance in biomedical research. The use of conventional ﬂuorescent microscopy for this purpose is limited due to its relatively
low spatial resolution compared to the size of a single protein molecule. Atomic force microscopy (AFM), on the other hand,
allows one to achieve single-protein resolution by scanning the cell surface using a specialized ligand-coated AFM tip. However,
because this method relies on short-range interactions, it is limited to the detection of binding sites that are directly accessible to
the AFM tip. We developed a method based on magnetic (long-range) interactions and applied it to investigate the structural
organization and distribution of endothelin receptors on the surface of smooth muscle cells. Endothelin receptors were labeled
with 50-nm superparamagnetic microbeads and then imaged with magnetic AFM. Considering its high spatial resolution and
ability to ‘‘see’’ magnetically labeled proteins at a distance of up to 150 nm, this approach may become an important tool for inves-
tigating the dynamics of individual proteins both on the cell membrane and in the submembrane space.INTRODUCTIONMembrane surface proteins play a pivotal role in cellular
function. It is well accepted that most of the components
of the cell membrane, e.g., ion channels, receptors, and
exchangers, have a complex multimeric structure and are
often localized in specialized membrane regions such as lipid
rafts and caveolae. The investigation of the structure and
distribution of membrane proteins and their complexes on
the surface of living cells, however, presents an enormous
challenge and currently is chiefly limited to fluorescence
imaging techniques. Such techniques involve the labeling
of protein macromolecules with specific antibodies, which
are then targeted by fluorescent probes (1). Recent advances
in fluorescence microscopy, combined with the development
of genetically coded fluorescent proteins (2) and quantum
dots (3), have significantly improved our understanding of
the functional and temporal dynamics of intracellular
proteins. However, imaging of individual proteins remains
beyond the resolution of optical instruments (4). This is
due to the inherent limitations of optical instruments, whose
resolution is restricted by the wavelength of the light. The
invention of the atomic force microscope has opened up
a novel approach for studying individual proteins, their
topography, and protein-protein interactions at the nanoscale
level. It is currently the only technique that can provide
nanometer resolution under the physiological conditions
required for living cells. Atomic force microscopy (AFM)
imaging has revealed fine structures of bacteriorhodopsins
in isolated bacterial membranes (5) (for a review, see Fred-
erix et al. (6)), nuclear pore complexes in the nuclear
envelope (7–9), gap junctions (10), and receptors (11,12)
overexpressed in mammalian cell lines. Also, multimeric
structures of purified isolated receptors and ion channelSubmitted July 6, 2009, and accepted for publication October 15, 2009.
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(13–18). The recent development of simultaneous topog-
raphy and recognition imaging (19,20) has significantly
increased the lateral resolution, allowing visualization of
individual protein molecules. Despite this progress, how-
ever, the identification of specific proteins on the surface
of intact cells by AFM remains a challenging task and relies
entirely on direct interactions between the functionalized
(ligand-coated) AFM probe and a corresponding protein
target. However, the functionalized AFM tip usually has
a relatively short lifetime due to the instability of attached
functional ligands (for review, see Hinterdorfer and Dufreˆne
(21)). In recent studies using magnetically coated AFM
cantilevers, interactions between streptavidin molecules
attached to a self-assembled monolayer or to a modified glass
surface and biotin-coated magnetic nanoparticles were dem-
onstrated using the magnetic mode of AFM (MFM) (22,23).
In these two studies, magnetic nanoparticles were either
chemically derived (22) or isolated from magnetotactic
bacteria (23). Here, we further developed this new methodo-
logical approach and applied it to investigate the distribution
of endothelin (ET) receptors on the surface of intact rat
aortic smooth muscle cells (SMCs). We used an innovative
labeling approach to specifically tag ET-1, a potent and
highly specific endogenous agonist of ET receptors, with
superparamagnetic microbeads (~50 nm in diameter). Mag-
netically labeled receptors were then detected and imaged
by AFM and MFM. The choice of cell type (ET-1 and ET
receptors) for this study was dictated by a several consider-
ations. From a functional point of view, the ET receptors
(which mainly consist of two subtypes, ETA and ETB) play
an important role in the cardiovascular system under physi-
ological conditions and in various disease states (24).
Biochemical, ligand-binding, and functional studies have
demonstrated that vascular SMCs endogenously express
both subtypes of the ET receptors, with the ETA subtypedoi: 10.1016/j.bpj.2009.10.021
Single-Molecule Imaging with MFM 479being generally dominant (25). However, the distribution
and organization of receptors on the surface of intact
vascular cells at the molecular level have only been studied
in the vascular wall of the capybara basilar artery using
electron microscopy (26). Another important consideration
was the highly specific and potent binding of ET-1 with
the receptor and its extremely slow dissociation from the
receptor, which make interactions between the ET receptor
and ET-1 virtually irreversible (27). These features of the
agonist-receptor interaction should facilitate preparation of
ET-1-treated cells for AFM and MFM imaging without
a significant loss of the agonist-receptor complexes. Also,
because ET-1 is a short 21-amino acid peptide containing
two primary amines, at a lysine-9 residue and a cysteine-1
residue at the N-terminus, it can be biotinylated using a stan-
dard procedure and then targeted with anti-biotin-coated
superparamagnetic nanoparticles for MFM imaging. Finally,
since ET-1 binds equally well to both ET receptor subtypes,
its usage would maximize the number of endogenous
agonist-receptor complexes available on the cell surface for
high-resolution MFM imaging.MATERIALS AND METHODS
Isolation of rat aortic SMCs and primary cell
culture
Thoracic aortas were taken frommaleWistar rats (250–300 g) after they were
humanely killed by cervical dislocation in accordance with the UK Home
Office legislation and guidelines. The thoracic aorta was cleaned of connec-
tive tissue and cut into pieces (~2 mm2) in a cold HEPES-buffered saline
solution (HBS) of the following composition (in mM): 130 NaCl, 5 KCl,
1.2 MgCl2, 1.5 CaCl2, 10 HEPES, 10 glucose. Single SMCs were obtained
by means of a modified enzymatic isolation procedure described previously
(28). Pieces of tissue were placed in cold Ca2þ, Mg2þ-free HBS containing
0.1 mg/mL bovine serum albumin (BSA, fraction V; Sigma, Gillingham,
UK) for 10min and then incubated for 20min at 37C in a fresh 2mLof Ca2þ,
Mg2þ-free HBS digestion solution containing 1 mg/mL BSA, 2 mg/mL
collagenase typeXI, 1mg/mL papain, 1mg/mLdithiothreitol, and 0.5mg/mL
trypsin inhibitor (all from Sigma), followed by another 20 min incubation at
37C in a fresh digestion solution. Pieces of tissue were then gently triturated
in fresh Ca2þ, Mg2þ-free HBS to yield cells. The cell suspension was centri-
fuged at 1100 g for 12min and then the cell pellet was resuspended in 5mL
of fresh HBS or Dulbecco’s modified Eagle’s medium (DMEM)/F-12 media
(Invitrogen, Paisley, UK) for primary cell culture (29). The DMEM/F-12
also contained 30 mg/mL penicillin-streptomycin and 0.25 mg/mL fungizone
(all from Invitrogen). For AFM and MFM imaging, cells were plated on
9 mm sterile glass coverslips and cultured for 48 h in a humidified cell
CO2 incubator (LEEC, Nottingham, UK).
Cell biotinylation
SMCs were treated for 30 min at room temperature (RT) with freshly
prepared biotinylation solution containing nine volumes of phosphate-buff-
ered saline (PBS; Sigma), one volume of 1 M sodium bicarbonate and
0.5 mg/mL water soluble biotin-XX sulfosuccinimidyl ester (SSE) (Invitro-
gen), pH ¼ 8.0. The cells were gently agitated (every 5 min for freshly
isolated cell suspension) or rotated at 20 times/min (primary cultured on
microscope coverslips). Biotinylation was terminated by washing the cells
four times with fresh PBS, one time with 100 mM glycine in PBS, and two
timeswith ice-cold PBS. Primary cultured SMCswere fixedwith 3% parafor-maldehyde (PFA) (30 min) and then washed with 0.1 mg/mL BSA in PBS
(10min,RT) before thebiotinylationprocedurewasperformed. Freshly isolated
cells were first biotinylated, then concentrated by centrifugation at 1100  g
for 12 min during the termination procedure, and plated on glass coverslips
before the fixation procedure was performed as described for cultured SMCs.
Biotinylation of ET-1 and its bioavailability
Biotinylation of ET-1 (100 mg; Sigma) was performed with the Biotin-XX
Microscale Protein Labeling kit (B30010; Invitrogen) according to the
manufacturer’s instructions, except that centrifugation at 14,000  g for
90 s (instead of the recommended 16,000  g for 15 s) was used to purify
biotinylated ET-1 (bET-1) from unbound biotin-XX SSE. Also, 100 mM of
glycine were added to the filtered solution to stop remaining reactions and
quench unbound labeling reagent (30). The concentration of protein was
measured with the use of Bradford reagent. bET-1 was aliquoted and stored
at 20C.
The functional bioavailability of bET-1 was verified in intact rat small
mesenteric arteries (third branch) using a small vessel wire myograph (meth-
odological details are given in the Supporting Material). The results clearly
demonstrate that the biotinylation procedure did not impair the ability of
ET-1 to constrict blood vessels (see Fig. S1).
Cell labeling with bET-1
Fixed primary cultured SMCs were incubated with 200 nM of biotinylated
ET-1 (bET-1) in PBS (15 min, RT), washed several times with fresh PBS,
and treated with either fluorescein isothiocyanate (FITC) for confocal
imaging or superparamagnetic microbeads for AFM/MFM imaging. Fixa-
tion of cells was used to minimize potential internalization of activated
ET receptors (31–33).
FITC labeling and confocal imaging
After biotinylation and fixation were achieved, cells were incubated with
FITC-conjugated anti-biotin rabbit antibody (1:150 in PBS containing
0.1 mg/mL BSA) for 90 min. To ensure that acetone dehydration (which
was used for cultured SMCs treated with superparamagnetic microbeads
for AFM/MFM imaging) did not affect cell labeling, cultured SMCs (bioti-
nylated or treated with bET-1) were initially incubated in ice-cold acetone
for 10 min, allowed to dry, and then incubated with anti-biotin rabbit anti-
body-FITC as described above. FITC-labeled cells were visualized with
a Zeiss LSM 510 or LSM 300 Olympus confocal microscope equipped
with a Plan-Apochromat 63/1.4 oil DIC or Plan-Neofluar 40/1.3 oil
objective. An excitation wavelength of 488 nm and emission bandwidth
of 505–530 nm were used to record FITC fluorescence. Control cell samples
were prepared in the same way, except that the biotinylation procedure was
excluded, and imaged under the same settings. Images were analyzed using
the software program LSM 510 v. 4.0 (Carl Zeiss, Welwyn Garden City,
UK) or Fluoview v. 5.0 (Olympus, Southend-on-Sea, UK).Cell labeling with superparamagnetic microbeads
and AFM/MFM imaging
Biotinylated or bET-1-labeled cultured aortic SMCs were gently rotated
with anti-biotin-coated superparamagnetic microbeads (MACS, Miltenyi
Biotec, Woking, UK; 1:10 dilution of the supplied stock solution in 2 mL
of PBS containing 0.5% BSA and 2 mM EDTA) for 30 min (RT) and
then washed four times with fresh PBS. To ensure firm binding of the
microbeads to biotinylated cells or to bET-1 bound to the receptors, a post-
fixation procedure was applied that included treatment of cells with 4% PFA
and 2% glutaraldehyde in PBS (15 min, RT) followed by washing several
times with PBS and washing for 5 min with MilliQ water. Cells were then
dehydrated with a gradually increasing concentration of ethanol in water
(25%, 50%, 75%, and 100%) and in a 50% acetone/ethanol mixture (eachBiophysical Journal 98(3) 478–487
FIGURE 1 Labeling method and
imaging of biotinylated intact rat aortic
SMCs. (A) Schematics of the cell bioti-
nylation and AFM/MFM imaging pro-
cedure, showing the key steps of cell
membrane biotinylation with biotin
XX (step 1), labeling with anti-biotin-
coated superparamagnetic microbeads
(step 2), and imaging with the AFM/
MFM probe (step 3). (B and C) Con-
focal images of freshly isolated (B)
and primary cultured (C) rat aortic
SMCs were biotinylated as shown in A
(step 1), but labeled with anti-biotin-
conjugated FITC instead of magnetic
microbeads (step 2). Confocal images
were used to verify the experimental
procedure before magnetic labeling.
The left and right panels in B and C
compare fluorescent and superimposed
fluorescent and transmitted light
images, respectively. Scale bars are
50 mm.
480 Moskalenko et al.for 5 min), followed by a 10 min incubation in pure acetone and air-drying.
The cell dehydration procedure and AFM/MFM imaging were performed in
a clean-room environment with controlled temperature (23C) and humidity
(45%). It is worthwhile to note that commercially purchased magnetic anti-
biotin-coated microbeads, which were used for labeling in our experiments,
have a magnetic (iron oxide) core and a total diameter of ~50 nm according
to their specifications. This was independently confirmed by scanning elec-
tron microscopy (not shown). Of importance, it was previously demon-
strated that these microbeads are superparamagnetic (34), i.e., their magnetic
moments change randomly in time at RT in the absence of applied magnetic
fields. This is because the energy required to change the direction of magne-
tization of the superparamagnetic nanoparticle is smaller than the thermal
energy kT. Therefore, MFM imaging was performed on the top of a perma-
nent magnet that produces a vertical magnetic field of 85 Oe to polarize the
superparamagnetic microbeads and increase the strength of the magnetic
interaction between the MFM tip and microbeads, thus increasing the
signal/noise ratio.
AFM and MFM imaging was performed using silicon cantilevers coated
with a 100 nm layer of cobalt-chromium alloy (high-moment MFM probes;
Asylum Research, Bicester, UK) at RT. These probes have a spring constant
of 1–2 N m1, a resonant frequency of 55–90 kHz, and a coercive field of
500–650 Oe. Images were taken using a VEECO Multimode IIIa atomic
force microscope. The scan rate was 0.1–1 Hz, depending on the scanned
area, with a resolution of 256 pixels per line. Pseudo-three-dimensional
(3D) AFM images were generated using WSxM software (35).RESULTS AND DISCUSSION
Labeling method and its veriﬁcation with confocal
imaging
The method for high-resolution imaging of membrane
proteins by AFM and MFM is depicted in Fig. 1 A. Target
proteins are labeled with biotin (step 1), which is then recog-
nized by anti-biotin-coated microbeads containing superpar-
amagnetic nanoparticles (step 2). The labeled cell surface is
then scanned with an oscillating AFM probe coated with
a thin magnetic layer (step 3). While working in the MFMBiophysical Journal 98(3) 478–487mode, the AFM scans each line twice: initially in the AFM
tapping mode, creating a topographic image, and then in
the MFM lift mode (i.e., at a certain distance from the
surface), which allows the detection of magnetic forces and
creates a magnetic image of the same area. To demonstrate
and characterize the major advantages of combined AFM
and MFM imaging, proteins on the surface of rat aortic
SMCs were nonselectively labeled with water-soluble
biotin-XX SSE as described in Materials and Methods.
This procedure should predominantly biotinylate the primary
amines of lysine and N-termini of proteins on the extracel-
lular surface of the cells (36). To confirm successful biotiny-
lation of membrane proteins, biotinylated SMCs were
initially labeled with the fluorescent marker FITC conjugated
to anti-biotin antibodies and imaged using confocal micros-
copy. Fig. 1 B shows that the fluorescent signal is located
peripherally (left) and overlaps with the boundaries of freshly
isolated rat aortic SMCs, thus indicating that only extracel-
lular proteins are labeled using this approach. Since subse-
quent AFM/MFM imaging was performed on primary
cultured cells (because they have a relatively smaller height,
and our AFM scanner has a height measurement limit of
2.7 mm), the same procedure was performed on rat aortic
SMCs cultured for 48 h. Fig. 1 C shows fluorescent signal
from cultured rat aortic SMCs labeled in the same way as
the freshly isolated cells shown in Fig. 1 B, confirming
successful staining of surface proteins. Note that the fluores-
cent signal is more diffused in cultured cells compared to
freshly isolated cells due to their flat geometry (compare
Fig. 1, B and C). Nevertheless, successful biotinylation of
both freshly isolated (first biotinylated and then fixed) and
primary cultured (first fixed and then biotinylated) rat aortic
SMCs suggests that cell fixation does not significantly hinder
labeling of the surface proteins.
Single-Molecule Imaging with MFM 481AFM and MFM imaging of biotinylated cells
labeled with superparamagnetic microbeads
AFM imaging of a small area of the cell surface (4 mm 
2 mm) of a biotinylated primary cultured SMC treated with
anti-biotin-coated superparamagnetic microbeads instead of
anti-biotin FITC revealed the presence of multiple bright
spots corresponding to elevated heights (see Fig. 2 A; a cor-
responding 3D reconstruction image is shown on the right).
Subsequent scanning of the same area of the cell with the
MFM probe (Fig. 2 B) showed a good correlation between
the AFM and MFM responses, suggesting that superpara-
magnetic microbeads are responsible for the majority of
these spots. Of interest, both the AFM and MFM images
of the biotinylated surface of intact SMCs labeled with
superparamagnetic nanoparticles resemble the AFM images
of immunoglobulins immobilized on the patterned mono-
layers (37).
The ability of MFM to sense the presence of magnetic
particles at a distance was tested by lifting the cantilever
up from 50 nm (the standard height) above the cell surface
to 100 and 150 nm (Fig. 2 B). Fig. 2 C compares the
MFM voltage profile of a selected particle (shown by whitelines in B) at different cantilever heights imaged with MFM,
and the AFM height (topographic) profile for the same
particle (shown by the black line and arrowhead in Fig. 2 A).
It can be clearly seen that MFM can sense the presence of
magnetically labeled proteins up to 150 nm above the cell
surface under our experimental conditions with no direct
physical contact with labeled molecules, which is an essen-
tial step in AFM imaging. This ability of MFM to ‘‘sense’’
magnetically labeled proteins at a distance could potentially
allow the investigation of magnetically labeled single mole-
cules not only on the surface of the membrane, but also
directly in the submembrane space after, for example,
receptor internalization. As demonstrated in Fig. 2 C, a mea-
surable magnetic response was achieved at lift heights of up
to 150 nm under our experimental conditions. The maximum
detection height will depend on the magnetic moment of the
nanoparticles and the magnetic properties of the MFM probe
(determined by the probe geometry and composition), the
size of the nanoparticles, and the magnetic field applied to
the specimen. All of these parameters can be precisely
controlled, allowing determination of the distance from the
cell surface to a magnetically labeled molecule and creatingFIGURE 2 Dependence of the magnetic signal on the lift
height of the MFM probe. (A) AFM image of biotinylated
cultured aortic SMCs in tapping mode (left) and a 3D
reconstruction (right) of a 4  2 mm area of the surface
of a biotinylated cell. (B) MFM images of the same area
at different lift heights as indicated above each panel. (C)
Line analysis of the AFM and MFM responses across the
selected area shown by straight lines in A and B, and by
an arrowhead in the 3D reconstruction image in A.
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FIGURE 3 Magnetic nature of MFM responses. (A)
Schematic of the experiment with the MFM probe polar-
ized vertically up (left picture) and vertically down (right
picture). (B) AFM images of two areas of a primary
cultured biotinylated SMC measured with the MFM tip
polarized ‘‘up’’ (left column) and ‘‘down’’ (right column).
(C) Corresponding MFM images for the two selected cell
areas. Note that for magnetic repolarization, the MFM
probe had to be removed from the instrument; therefore,
the images on the left and right do not exactly represent
the same area of the cell. (D) Comparison of the topo-
graphic (AFM) and magnetic (MFM) profiles (respectively
shown by straight lines in B and C) for a single superpara-
magnetic microbead for different polarizations of the MFM
tip. Black and blue lines depict variations in the AFM
height and the MFM voltage, respectively.
482 Moskalenko et al.an opportunity for 3D protein mapping in the submembrane
space, which is not possible with AFM alone.
Magnetic nature of MFM responses
The magnetic nature of the signal measured with MFM was
confirmed in experiments with inverse magnetic polarization
of the MFM probe. The schematic of this approach is demon-
strated in Fig. 3 A. Fig. 3, B and C, respectively show the
AFM and MFM images for the MFM probe polarized verti-
cally down (right) and vertically up (left), whereas the
magnetic microbeads were polarized up using an externally
applied magnetic field (see Materials and Methods). Fig. 3 D
compares cross-sectional analyses of a selected superpara-
magnetic bead in the AFM andMFM images for the opposite
polarizations of the MFM probe. The change in sign for the
magnetic but not the topographic responses with reversed
polarization suggests that magnetic responses are indeed
measured in the MFM mode.Biophysical Journal 98(3) 478–487Mapping of individual ET receptors in intact SMCs
The methodological approach described above was then
adapted to investigate the distribution of ET receptors on
the surface of SMCs, as schematically depicted in Fig. 4 A.
ET receptors (which are ubiquitously expressed in the vascu-
lature) are activated by the agonist ET-1, leading to vessel
constriction (25). The ET-1 peptide is composed of 21
amino acids and includes one lysine residue at position 9
(24); thus it possesses two primary amines, on lysine-9 and
cysteine-1 at the N-terminus. These can be biotinylated
(step 1; see Materials and Methods for details) before
applying ET-1 on SMCs (step 2). Receptor-bound biotiny-
lated ET-1 (bET-1) will be recognized by anti-biotin-coated
superparamagnetic microbeads (step 3) and then visualized
with the AFM/MFM probe (step 4). To independently verify
this methodological approach and confirm that bET-1 was
able to recognize ET receptors on the cell surface, cells
were labeled with 100 nM of bET-1 and then imaged by
FIGURE 4 Method for visualizing ET receptors in bioti-
nylated cultured SMCs, and AFM/MFM imaging verified
by confocal microscopy. (A) Schematics of the experi-
mental procedure. The key steps include biotinylation of
ET-1 (step 1), labeling of the surface ET receptors with
bET-1 (step 2), labeling of bET-1 bound to the receptor
with anti-biotin-coated superparamagnetic microbeads
(step 3), and imaging of the labeled receptors with AFM/
MFM (step 4). (B) Confocal imaging of cultured cells
treated with 100 nM bET-1-and then labeled with anti-
biotin FITC-conjugated antibodies instead of anti-biotin-
coated superparamagnetic microbeads. The bottom panel
shows superimposed fluorescent and transmitted light
images. Scale bars are 50 mm.
Single-Molecule Imaging with MFM 483confocal microscopy. Cultured SMCs were fixed with 3%
PFA (to prevent possible internalization of activated recep-
tors) before bET-1 treatment and then labeled with anti-
biotin conjugated FITC. Confocal images of a representative
group of cells thus treated are shown in Fig. 4 B, demon-strating successful labeling of cells. Of interest, both diffused
and bright-spot fluorescent signals were observed, suggest-
ing uneven distribution and perhaps clustering of ET recep-
tors in SMCs. The bright spots (Figs. 4 and 5 C) are likely
due to a specific interaction between bET-1 and ETFIGURE 5 Specificity of bET-1
labeling. (A–C) Confocal images of pri-
mary cultured aortic SMCs: nontreated
(control) (A), pretreated with 200 nM
of nonmodified ET-1 and then treated
with bET-1 (100 nM) (B), and treated
with bET-1 (100 nM) (C).
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FIGURE 6 AFM/MFM imaging of
ET receptors on the surface of aortic
SMCs. (A) AFM image (50  30 mm)
of the surface area of a cultured SMC.
(B) AFM images of three selected areas
at high spatial resolution (2.5 2.5 mm)
shown by squares 1–3 in A (upper
panels) and their corresponding 3D
reconstruction (bottom panels). (C)
Corresponding MFM images of the
three areas shown in B. Note a cor-
relation between amplitude heights
measured with AFM and magnetic
responses measured with MFM, con-
firming the specificity of the receptor
labeling. (D) Line section analysis of
the AFM topographic (black lines) and
MFM magnetic (blue lines) responses
for two individual ET receptors (i) and
two receptor complexes (ii and iii)
marked by straight lines in the third
selected area (right columns in B
and C).
484 Moskalenko et al.receptors, because the pretreatment of cells with an excess of
nonbiotinylated ET-1 (200 nM) before cell incubation with
bET-1 inhibited the FITC fluorescent signal (Fig. 5 B), which
did not differ from that measured in control untreated cells
(Fig. 5 A).Biophysical Journal 98(3) 478–487Cells labeled with bET-1 were then treated with anti-
biotin-coated superparamagnetic microbeads and subjected
to AFM and MFM imaging. Fig. 6 A shows an AFM image
of the surface of a cultured SMC at low resolution. To visu-
alize individual proteins, three different surface areas of the
Single-Molecule Imaging with MFM 485cell (shown by squares labeled 1–3 in Fig. 6 A) were imaged
with AFM at high spatial resolution (Fig. 6 B). Analysis of
these AFM images revealed distinctive white spots on the
surface of the SMCs, which can be clearly seen as topo-
graphic peaks in the 3D reconstruction (bottom panels in
Fig. 6 B). Of interest, high-resolution AFM imaging revealed
that these topographic features are distributed on the cell
surface both as individual peaks and as complexes of various
sizes. Subsequent MFM imaging of the same areas (Fig. 6 C)
revealed a nearly perfect match between the AFM and MFM
responses, suggesting that the topographic peaks in the AFM
images represent ET receptors selectively labeled with super-
paramagnetic microbeads. It is noteworthy that the line
cross-section analysis shown in Fig. 6 D (panel 3i), which
compares the AFM height and MFM voltage profiles, clearly
demonstrates three distinctive amplitude peaks with AFM
and only two with MFM, indicating the presence of only
two ET receptors. Therefore, the use of MFM in addition
to AFM imaging offers an additional opportunity to distin-
guish between specifically magnetically labeled receptors
and other nonspecific topographic features present on the
cell surface. This advantage of MFM/AFM imaging is
further illustrated by control experiments in which nonbioti-
nylated cells were treated with superparamagnetic microbe-
ads (Fig. S2). The distinctive topographic features seen in
the AFM image (Fig. S2 A) are absent in the MFM image
of the same cell area (Fig. S2 B; also see the line analysis
in Fig. S3 C). These data also confirm the absence of nonspe-
cific interactions of anti-biotin-coated microbeads with the
cell surface of nonbiotinylated control cells, and thus inde-
pendently support the results obtained in control experiments
with FITC described above and in Fig. 5.
Furthermore, these results suggest that native ET receptors
can exist as large receptor complexes (conglomerates) in
intact aortic SMCs. The AFM topographic and MFM mag-
netic profiles for two separate receptors and the two receptor
conglomerates (straight lines denoted as i, ii, and iii in the
third square in the AFM image in B and the MFM image
in C) are compared in Fig. 6 D. This analysis demonstrates
a complex organization of the receptor conglomerate, which
could be composed of three to five individual ET receptors
(e.g., panel 3iii in Fig. 6 D). It is unlikely that such conglom-
erates are due to multiple magnetic particles bound to bET-1,
as only two potential biotinylated sites (cystein-1 and
lysine-9 residues) per the agonist are available. A computa-
tional molecular analysis of the interaction between ET-1
and the ET receptor suggests that cystein-1 at the N-terminus
and lysine-9 of ET-1 preserve a substantial accessible area
after the agonist docks into the receptor (38), and therefore
either of the biotinylated amino acid residues might theoret-
ically interact with an anti-biotin-coated microbead or an
FITC molecule. On the other hand, numerous functional
studies suggest that the N-terminus is essential for selective
interaction with ETA receptors (27). Also, the removal of
cysteine-1 at the N-terminus renders ET-1 inactive in theintact rat aorta, where the ETA receptor subtype is dominant
(39). These observations may indicate that cysteine-1 at the
N-terminus of ET-1 may not be easily accessible for molec-
ular interaction. Furthermore, selective biotinylation of ET-1
on lysine-9 did not alter its functional activity against the
ETA receptors (40), thus supporting our functional studies
with bET-1 shown in Fig. S1. Finally, taking into account
that in our labeling procedure the biotinylated agonist first
binds to the receptor and then interacts with superparamag-
netic microbeads, and considering that the two biotinylated
sites in the ET-1 molecule are likely to be in close proximity
to each other (due to the presence of two disulfide bonds), it
is reasonable to speculate that only one biotinylated site
per ET-1 molecule would be available for the interaction
with a superparamagnetic microbead or an FITC molecule,
perhaps at lysine-9. However, further focused structural
studies will be necessary to address the question as to which
biotinylated amino acid in ET-1 is mainly responsible for the
interaction with superparamagnetic beads.
The existence of receptor conglomerates on the surface of
SMCs observed in high-resolution AFM/MFM images could
explain the existence of the bright spots of fluorescence
observed on the surface of FITC-labeled SMCs (Fig. 6 B).
Although intracellular conglomerates of ET receptors were
previously demonstrated in vascular endothelial cells by
means of gold particle immunostaining and electron micros-
copy (26), this is the first direct demonstration (to our knowl-
edge) of ET receptor clusters on the surface of native cells. It
is noteworthy that previous reports demonstrated colocaliza-
tion of ET receptors with caveolin in COS cells (where
ETA receptors were overexpressed) (41) and association of
endogenous ETA and ETB receptors with lipid rafts in pri-
mary cultured rat peritubular SMCs (42). However, in our
preparation, the bright spots of FITC fluorescence (which
may be associated with ET receptor clusters) were not clearly
associated with the fluorescence caveolin-1 Cy3 conjugate
when examined under confocal microscope (Fig. S3).
Also, the size of the largest cluster visualized by AFM/
MFM imaging is greater than the typical size of caveolae
(50–100 nm). These results suggest that ET receptor clusters
in rat aortic SMCs may be organized in a different manner
and may not be necessarily associated with caveolae,
although colocalization of individual receptors or small
receptor groups with caveolae cannot be excluded.
In conclusion, we have successfully applied the novel
methodological approach that combines AFM and MFM to
study specific macromolecules on the surface of intact cells
with nanoscale resolution. MFM imaging depends on long-
range (noncontact) interactions between the MFM probe
and the target protein, in contrast to AFM imaging, which
relies on measurement of the force of short-range (contact)
interactions between target proteins and a functionalized
(ligand-coated) AFM tip. The combined use of AFM and
MFM for molecular mapping therefore offers a range of
advantages, such as 1), the potential ability to map individualBiophysical Journal 98(3) 478–487
486 Moskalenko et al.molecules in the submembrane space; 2), a higher level of
accuracy in determining the distribution of specific mole-
cules; 3), less physical distortion of molecules on the cell
surface, due to decreased direct interactions between target
molecules and the MFM tip (although AFM topographic
scanning is a necessary initial step in the MFM imaging, it
is performed in the tapping mode with a nonfunctionalized
MFM probe); and 4), an increased lifetime of MFM tips
compared to functionalized (ligand-coated) AFM tips, allow-
ing a greater number of scans of the cell surface.
MFM imaging provides high lateral resolution for
protein mapping, comparable to that of AFM (Fig. 6 D). In
our case, it was limited to 50 nm (i.e., the size of commer-
cially acquired superparamagnetic microbeads). However,
Schreiber and colleagues (34) demonstrated that 15 nm
superparamagnetic nanoparticles could be detected by
MFM at RT. Recently, Kaiser et al. (43) demonstrated that
subnanometer-scale magnetic imaging is achievable with
the use of an atomically sharp magnetic tip. Therefore, one
can expect that the use of smaller magnetic nanoparticles
and a sharper MFM probe in future studies will significantly
improve the lateral resolution of this method.
Although we performed our experiments on fixed cells to
characterize and verify this methodological approach, MFM
imaging could also be adopted to study protein dynamics in
live cells, since AFM was previously used to study the
surface topography of living cells in solution (44,45). This
offers a potential advantage of AFM/MFM imaging over
electron microscopy, which delivers a comparable resolution
but cannot be used in live cells.SUPPORTING MATERIAL
Verification of functional bioavailability of ET-1 and references, and three
figures, are available at http://www.biophysj.org/biophysj/supplemental/
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